Advertisement
Advertisement
TECH
Bio-Techne Corp.
48.21
USDSponsored
+0.84
+1.77%
May 22, 16:00 UTC -4
Closed
Pre-Market
48.58
+0.37
+0.77%
TECH Earnings Reports
Positive Surprise Ratio
TECH beat 25 of 41 last estimates.
61%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q4 26 (Revenue/ EPS)
$322.04M
/$0.53
Implied change from Q3 26 (Revenue/ EPS)
+3.41%
/--
Implied change from Q4 25 (Revenue/ EPS)
+1.60%
/--
Bio-Techne Corp. earnings per share and revenue
On May 06, 2026, TECH reported earnings of 0.53 USD per share (EPS) for Q3 26, missing the estimate of 0.54 USD, resulting in a -3.34% surprise. Revenue reached 311.42 million, compared to an expected 323.43 million, with a -3.72% difference. The market reacted with a -16.36% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 16 analysts forecast an EPS of 0.53 USD, with revenue projected to reach 322.04 million USD, implying an increase of 0.00% EPS, and increase of 3.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Belite Bio, Inc - ADR
Report Date
May 20, 2026 For Q1 26
Estimate
-$0.64
Actual
-$0.68
Surprise
-4.87%
Immunovant, Inc. Common Stock
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.61
Actual
-$0.73
Surprise
-19.11%
Roivant Sciences Ltd. Common Shares
Report Date
May 20, 2026 For Q4 26
Estimate
-$0.35
Actual
-$0.57
Surprise
-64.63%
Compugen Ltd
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.08
Surprise
-8.11%
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
Scilex Holding Company Common Stock
Report Date
May 20, 2026 For Q1 26
Estimate
-Actual
-$4.76
Surprise
-
MiNK Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.78
Actual
-$0.56
Surprise
+27.43%
OS Therapies Incorporated
Report Date
May 18, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.27
Surprise
-49.83%
Annovis Bio, Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.40
Actual
-$0.63
Surprise
-56.37%
Akari Therapeutics plc ADR (0.01 USD)
Report Date
May 19, 2026 For Q1 26
Estimate
-$1.40
Actual
-$1.57
Surprise
-11.81%
FAQ
What were Bio-Techne Corp.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Bio-Techne Corp. reported EPS of $0.53, missing estimates by -3.34%, and revenue of $311.42M, -3.72% below expectations.
How did the market react to Bio-Techne Corp.'s Q3 2026 earnings?
The stock price moved down -16.36%, changed from $56.68 before the earnings release to $47.41 the day after.
When is Bio-Techne Corp. expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Bio-Techne Corp.'s next earnings report?
Based on 16
analysts, Bio-Techne Corp. is expected to report EPS of $0.53 and revenue of $322.04M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement